Cargando…

An implementation of a hybrid method based on machine learning to identify biomarkers in the Covid-19 diagnosis using DNA sequences

Although some people do not have any chronic disease or are not in the risky age group for Covid-19, they are more vulnerable to the coronavirus. As the reason for this situation, some experts focus on the immune system of the person, while others think that the genetic history of patients may play...

Descripción completa

Detalles Bibliográficos
Autor principal: Das, Bihter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528020/
https://www.ncbi.nlm.nih.gov/pubmed/36213553
http://dx.doi.org/10.1016/j.chemolab.2022.104680
_version_ 1784801205689516032
author Das, Bihter
author_facet Das, Bihter
author_sort Das, Bihter
collection PubMed
description Although some people do not have any chronic disease or are not in the risky age group for Covid-19, they are more vulnerable to the coronavirus. As the reason for this situation, some experts focus on the immune system of the person, while others think that the genetic history of patients may play a role. It is critical to detect corona from DNA signals as early as possible to determine the relationship between Covid-19 and genes. Thus, the effect on the severe course of the disease of variations in the genes associated with the corona disease will be revealed. In this study, a novel intelligent computer approach is proposed to identify coronavirus from nucleotide signals for the first time. The proposed method presents a multilayered feature extraction structure to extract the most effective features using an Entropy-based mapping technique, Discrete Wavelet Transform (DWT), statistical feature extractor, and Singular Value Decomposition (SVD), together. Then 94 distinctive features are selected by the ReliefF technique. Support vector machine (SVM) and k nearest neighborhood (k-NN) are chosen as classifiers. The method achieved the highest classification accuracy rate of 98.84% with an SVM classifier to detect Covid-19 from DNA signals. The proposed method is ready to be tested with a different database in the diagnosis of Covid-19 using RNA or other signals.
format Online
Article
Text
id pubmed-9528020
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-95280202022-10-03 An implementation of a hybrid method based on machine learning to identify biomarkers in the Covid-19 diagnosis using DNA sequences Das, Bihter Chemometr Intell Lab Syst Article Although some people do not have any chronic disease or are not in the risky age group for Covid-19, they are more vulnerable to the coronavirus. As the reason for this situation, some experts focus on the immune system of the person, while others think that the genetic history of patients may play a role. It is critical to detect corona from DNA signals as early as possible to determine the relationship between Covid-19 and genes. Thus, the effect on the severe course of the disease of variations in the genes associated with the corona disease will be revealed. In this study, a novel intelligent computer approach is proposed to identify coronavirus from nucleotide signals for the first time. The proposed method presents a multilayered feature extraction structure to extract the most effective features using an Entropy-based mapping technique, Discrete Wavelet Transform (DWT), statistical feature extractor, and Singular Value Decomposition (SVD), together. Then 94 distinctive features are selected by the ReliefF technique. Support vector machine (SVM) and k nearest neighborhood (k-NN) are chosen as classifiers. The method achieved the highest classification accuracy rate of 98.84% with an SVM classifier to detect Covid-19 from DNA signals. The proposed method is ready to be tested with a different database in the diagnosis of Covid-19 using RNA or other signals. Elsevier B.V. 2022-11-15 2022-10-03 /pmc/articles/PMC9528020/ /pubmed/36213553 http://dx.doi.org/10.1016/j.chemolab.2022.104680 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Das, Bihter
An implementation of a hybrid method based on machine learning to identify biomarkers in the Covid-19 diagnosis using DNA sequences
title An implementation of a hybrid method based on machine learning to identify biomarkers in the Covid-19 diagnosis using DNA sequences
title_full An implementation of a hybrid method based on machine learning to identify biomarkers in the Covid-19 diagnosis using DNA sequences
title_fullStr An implementation of a hybrid method based on machine learning to identify biomarkers in the Covid-19 diagnosis using DNA sequences
title_full_unstemmed An implementation of a hybrid method based on machine learning to identify biomarkers in the Covid-19 diagnosis using DNA sequences
title_short An implementation of a hybrid method based on machine learning to identify biomarkers in the Covid-19 diagnosis using DNA sequences
title_sort implementation of a hybrid method based on machine learning to identify biomarkers in the covid-19 diagnosis using dna sequences
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528020/
https://www.ncbi.nlm.nih.gov/pubmed/36213553
http://dx.doi.org/10.1016/j.chemolab.2022.104680
work_keys_str_mv AT dasbihter animplementationofahybridmethodbasedonmachinelearningtoidentifybiomarkersinthecovid19diagnosisusingdnasequences
AT dasbihter implementationofahybridmethodbasedonmachinelearningtoidentifybiomarkersinthecovid19diagnosisusingdnasequences